These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3485013)

  • 41. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract]   [Full Text] [Related]  

  • 42. The biochemical and clinical consequences of 2'-deoxycoformycin in T cell chronic lymphocytic leukaemia.
    Hallam LJ; Van der Weyden MB; Ackland SP; Bagnara AS; Whiteside MG
    Scand J Haematol; 1984 Jan; 32(1):55-64. PubMed ID: 6607510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aphidicolin and deoxycoformycin cause DNA breaks and cell death in unstimulated human lymphocytes.
    Brox L; Hunting D; Belch A
    Biochem Biophys Res Commun; 1984 May; 120(3):959-63. PubMed ID: 6428403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of X-ray-induced potentially lethal damage (PLD) repair by cordycepin (3'-deoxyadenosine) and enhancement of its action by 2'-deoxycoformycin in Chinese hamster hai cells in the stationary phase in vitro.
    Nakatsugawa S; Sugahara T
    Radiat Res; 1980 Nov; 84(2):265-75. PubMed ID: 6969408
    [No Abstract]   [Full Text] [Related]  

  • 47. Altered deoxynucleoside triphosphate levels paralleling deoxyadenosine toxicity in adenosine deaminase inhibited human lymphocytes.
    Bluestein HG; Thompson LF; Albert DA; Seegmiller JE
    Adv Exp Med Biol; 1980; 122A():427-31. PubMed ID: 6968502
    [No Abstract]   [Full Text] [Related]  

  • 48. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
    Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
    Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
    Hayward AR
    Clin Exp Immunol; 1980 Jul; 41(1):141-9. PubMed ID: 6969149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of purine metabolism in lymphocytes.
    Henderson JF; Smith CM; Zombor G
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):419-26. PubMed ID: 3875099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deoxyadenosine inhibits DNA synthesis in cultured human fibroblasts.
    Fox IH; Kaminska J; Wortmann RL; Halsey DL
    J Lab Clin Med; 1979 Jul; 94(1):52-9. PubMed ID: 313967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential production of deoxyadenosine by human T and B lymphoblasts.
    Iizasa T; Kubota M; Carson DA
    J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin.
    Johnston JB; Lee K; Verburg L; Blondal J; Mowat MR; Israels LG; Begleiter A
    Leuk Res; 1992 Aug; 16(8):781-8. PubMed ID: 1528066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for distinct catabolic pathways of adenine ribonucleotides and deoxyribonucleotides in human T lymphoblastoid cells.
    Barankiewicz J; Cohen A
    J Biol Chem; 1984 Dec; 259(24):15178-81. PubMed ID: 6334686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of human lymphocyte DNA and protein synthesis in vitro by adenosine and eight modified adenine nucleosides in the presence or in the absence of adenosine deaminase inhibitors, 2'-deoxycoformycin (DCF) and erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA).
    Ratech H; Kuritsky L; Thorbecke GJ; Hirschhorn R
    Cell Immunol; 1982 Apr; 68(2):244-51. PubMed ID: 6980056
    [No Abstract]   [Full Text] [Related]  

  • 56. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ; Buurman WA; van der Linden CJ
    J Immunol; 1987 Jan; 138(1):116-22. PubMed ID: 3097141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inability of poly-ADP-ribosylation inhibitors to protect peripheral blood lymphocytes from the toxic effects of ADA inhibition.
    Ganeshaguru K; Piga A; Latini L; Hoffbrand AV
    Adv Exp Med Biol; 1989; 253B():251-8. PubMed ID: 2532859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations in erythrocyte adenine nucleotide pools resulting from 2'-deoxycoformycin therapy.
    Koller CA; Mitchell BS
    Cancer Res; 1983 Mar; 43(3):1409-14. PubMed ID: 6600652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relative sensitivity of peripheral blood T-lymphocyte colony forming cells and bone marrow CFU-GM to deoxyadenosine and 2'deoxycoformycin.
    Russell NH; Carron J; Hoffbrand AV; Bellingham AJ
    Leuk Res; 1985; 9(2):315-9. PubMed ID: 3872974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. dATP-mediated inhibition of DNA ligase by 2'-deoxycoformycin in T and B cell leukemia.
    Lamballe F; Le Prise PY; Le Gall E; David JC
    Leukemia; 1989 Feb; 3(2):97-103. PubMed ID: 2783473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.